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Dear Editor,
We would like to highlight the further
consideration of the nervous system in
the mechanistic conclusions of the article
‘‘Activation of TRPV1 Dietary Capsaicin
Improves Endothelium-Dependent Vaso-
relaxation and Prevents Hypertension’’
(Yang et al., 2010). While the cellular
data localizing TRPV1 receptors and
demonstrating direct actions of capsaicin
on endothelial calcium signals is convinc-
ing, the chronic experiments critical for
the authors interpretations justify further
thoughts. In the first of these experiments,
the authors fed rats and mice large
amounts of the TRPV1 agonist capsaicin
(0.01%–0.02% in chow) for 7 months
and found modest reductions in systolic
blood pressure in spontaneously hyper-
tensive rats. At these levels of intake,
even very conservative estimates (consid-
ering bioavailability and blood buffering
capacity) of plasma circulating concen-
trations of capsaicin would reach into
the 10–100 nM range. Unfortunately, the
initial chronic experiments did not mea-
sure plasma levels, but a single dose
of gastric capsaicin generated high
(10 ng/ml) plasma concentrations lasting
more than 1 hr—or a sustained exposure
to 33 nM in plasma. In either case,
these pharmacological concentrations
of capsaicin may be sufficient to pro-
duce excitotoxic changes or widespread,
sustained, functional desensitization of
TRPV1. Such effects might be evident in
the authors’ food intake data (Figure S4,
Yang et al. [2010]), which shows initial
aversion to the capsaicin diet followed
by progressive return to normophagia
consistent with a desensitization or
recovery process. At a minimum theseconcentrations would result in strong
agonism of all accessible TRPV1 recep-
tors, including those expressed in the
nervous system, and suggests a number
of other pertinent considerations regard-
ing blood pressure and long-term conse-
quences of chronic dietary capsaicin.
In interpreting the blood-pressure
observations, it is worth considering
the nervous system and the importance
of long-recognized high-affinity TRPV1
receptors in cranial visceral afferents
(Coleridge and Coleridge, 1980). These
cranial visceral afferents include cardio-
vascular and noncardiovascular primary
vagal afferents that alter autonomic
nervous system regulation of the cardio-
vascular system via the solitary tract
nucleus (Andresen and Peters, 2008).
Chronic activation of arterial barorecep-
tors produces long-term reductions in
blood pressure (Lohmeier et al., 2010).
Arterial baroreceptors express TRPV1
receptors both peripherally as well as on
their central terminals (Doyle et al., 2002;
Andresen and Peters, 2008; Peters et al.,
2010) and represent a nondesensitizing
target with nM affinity for capsaicin
exposed through an open-blood brain
barrier. Thus, chronic activation of TRPV1
receptors on arterial baroreceptors would
be expected to lower blood pressure
without a sustained change in heart rate
(Lohmeier et al., 2010).
Further, a number of other neural
targets containing TRPV1 have the poten-
tial to alter blood pressure less directly.
TRPV1 receptors contribute to thermal
regulation and, through these pathways,
can alter blood flow and vessel function.
Gastrointestinal and other viscera provide
neural signals that chronically influenceCell Metabolism 12,feeding behaviors, nutritional balance,
and homeostatic outcomes that each
might contribute to blood-pressure out-
comes. In the time interval of these
chronic studies, potential trophic interac-
tions between sympathetic nerves and
blood-vessel function might also warrant
attention. While activation of TRPV1
at vascular endothelium may critically
contribute to vessel tone, a more compre-
hensive view of vanilloids and their
multiple TRPV1 actions will be necessary
to fully understand their antihypertensive
potential.
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